David Joshua Bartch, Chief Executive Officer at Mydecine Innovations Group, holds 1.48M shares in Mydecine Innovations Group (Ticker: TSE:MYCO). Most recently, David Joshua Bartch Bought C$600,000 shares of Mydecine Innovations Group on Jan 12, 2024 for an estimated value of 18.48K.
What is the percentage of profitable transactions made by David Joshua Bartch?
The percentage of profitable transactions made by David Joshua Bartch is 0%.
What is the average return per transaction made by David Joshua Bartch?
The average return per transaction made by David Joshua Bartch is 0.00%.
What stocks does David Joshua Bartch hold?
David Joshua Bartch holds: TSE:MYCO stocks.
What was David Joshua Bartch’s latest transaction?
David Joshua Bartch latest transaction was an Informative Buy of C$18.48K.
What was David Joshua Bartch's most profitable transaction?
David Joshua Bartch’s most profitable transaction was an Informative Buy of TSE:MYCO stock on September 15, 2022. The return on the trade was 0.00%.
What is David Joshua Bartch's role in Mydecine Innovations Group?
David Joshua Bartch's role in Mydecine Innovations Group is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.